v3 Template
C

Compass Pathways plc

Biotechnology / Mental Health London, UK ~480 employees
Founded
--
Employees (Est.)
~480
24 leaders known
Total Funding
$325.0M
Funding Rounds
3
Last Funding
2025-01-10

About Compass Pathways plc

Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Their mission is to reimagine mental health care by connecting science and compassion, focusing on investigational treatments for conditions like treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa.

Products & Services

COMP360 Psilocybin Therapy:An investigational psilocybin treatment studied for treatment-resistant depression (TRD), post-traumatic stress disorder (PTSD), and anorexia nervosa. It includes the largest randomized, controlled, double-blind study of psilocybin treatment ever conducted.
Therapist Training:Programs to train therapists in administering psilocybin therapy, with related publications and resources.
Digital Technologies:Innovations in digital platforms to support mental health care, including blogs and tools for enhancing treatment experiences.

Specialties

Psilocybin Therapy Treatment-Resistant Depression (TRD) Post-Traumatic Stress Disorder (PTSD) Anorexia Nervosa Therapist Training Digital Technologies for Mental Health

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Underwritten Offering
T: -
FT: Underwritten Offering
A: 150000000
MR: -
FA: $150 million
FAN: 150000000
D: 2025-01-10
FD: 2025-01-10
1 investors
2 RT: Private Placement
T: -
FT: Private Placement
A: 125000000
MR: -
FA: $125 million
FAN: 125000000
D: 2023-08-16
FD: 2023-08-16
11 investors
3 RT: Debt
T: -
FT: Debt
A: 50000000
MR: -
FA: up to $50 million
FAN: 50000000
D: 2023-07-05
FD: 2023-07-05
1 investors
Underwritten Offering Latest
2025-01-10
$150.0M
1 investor (Pro only)
Private Placement 2023-08-16
$125.0M
Debt 2023-07-05
$50.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

L

Linda McGoldrick

Independent Director

R

Robert McQuade

Independent Director

T

Thomas Lönngren

Independent Director

W

Wayne Riley

Independent Director

G

Gino Santini

Chairman of the Board

K

Kabir Nath

Chief Executive Officer

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

Compass Pathways plc Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Mental Health
Company Size
~480 employees (est.)
Locations
London, UK

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro